Related Experiment Videos
Type 2 Diabetes Mellitus: Interplay Among Biological, Environmental, and Socioeconomic Determinants in Disease
Ilderbayeva Gulzhan1, Tatayeva Rosa2, Tazhibayeva Damira3
1Department of Biotechnology and Microbiology, L.N.Gumilyov Eurasian National University, 010008, 2 Satbaev St., Astana, Republic of Kazakhstan.
Background:
Type 2 Diabetes Mellitus (T2DM) is a complex metabolic disorder characterized by insulin resistance and progressive β-cell dysfunction, although these mechanisms alone do not account for the considerable variability observed in disease presentation and clinical evolution. During the last decade, epidemiological and mechanistic studies have shown that metabolic dysfunction develops within a broader framework in which biological susceptibility is continuously shaped by environmental exposures, occupational conditions, lifestyle-related behaviors, psychosocial influences, and socioeconomic circumstances. Rather than acting independently, these factors appear to modify metabolic regulation through interconnected biological pathways that contribute to differences in disease susceptibility, progression, and long-term outcomes across populations. This perspective supports a more integrated interpretation of T2DM pathophysiology, in which biological, environmental, and socioeconomic influences jointly determine disease expression. Accordingly, this review critically evaluates current evidence regarding the contribution of these interacting determinants to the onset, progression, and clinical manifestations of T2DM.
Methods:
This narrative review was based on publications retrieved from PubMed, Scopus, and Web of Science addressing biological, environmental, behavioral, occupational, and socioeconomic factors relevant to T2DM. Epidemiological, clinical, and experimental studies were selected to provide complementary evidence on the mechanisms through which these variables contribute to metabolic dysfunction, disease progression, and diabetes-related complications. Particular attention was given to investigations examining the interplay among these factors rather than considering them as isolated contributors to disease development.
Results:
The literature examined indicates that T2DM arises through the convergence of multiple pathogenic processes rather than from a single metabolic abnormality. Obesity, insulin resistance, sedentary lifestyles, and dietary imbalance remain central contributors to disease development, while increasing evidence also points to a relevant contribution from environmental exposures and socioeconomic conditions. Pollutants, adverse occupational settings, chronic psychosocial stress, and inequalities in healthcare access have all been associated with disturbances in metabolic regulation and less favorable clinical outcomes. Delayed diagnosis, limited preventive strategies, and insufficient diabetes education further compromise long-term disease management and may contribute to the persistence of chronic complications.
Discussion:
T2DM arises from metabolic alterations driven by environmental and socioeconomic factors that can modify disease susceptibility and clinical evolution. Differences in disease burden observed across populations are unlikely to result from isolated determinants; instead, they appear to reflect the cumulative influence of environmental exposures, social conditions, and biological vulnerability. Their combined effects may promote chronic inflammation, oxidative stress, and progressive impairment of glucose homeostasis, although the relative contribution of each determinant probably differs according to the characteristics of the population studied.
Conclusion:
The persistent global increase in T2DM highlights the need for preventive and therapeutic strategies that extend beyond glycemic control alone. Addressing environmental exposures, socioeconomic inequalities, healthcare accessibility, and lifestyle-related factors alongside conventional metabolic management may improve long-term clinical outcomes and reduce the burden of diabetes-related complications. A broader understanding of how these determinants interact will also facilitate the development of more effective public health policies and individualized therapeutic approaches.
Related Concept Videos
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis